Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J9145 |
Short Description | Injection, daratumumab 10 mg |
Long Description | Injection, daratumumab, 10 mg |
Pricing indicator | 51 |
Coverage code | D |
ASC payment group code | YY |
BETOS2 code | O1D |
Action code | N |
Type of service | 1 |
Effective date | 2017-01-01 |
Date Added | 2017-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
57894050205 | J9145 | Injection, daratumumab 10 mg | Darzalex | JANSSEN BIOTECH, INC. | 10 MG | 5 | 1 | 10 | 10 |
57894050220 | J9145 | Injection, daratumumab 10 mg | Darzalex | JANSSEN BIOTECH, INC. | 10 MG | 20 | 1 | 40 | 40 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 10 MG |
HCPCS/CPT Billing Units | 0.1 |
Total doses ordered | |
Billing Units | 0.1 |
Drug Details
-
Daratumumab injection is used alone or in combination with other medications to treat multiple myeloma (a type of cancer of the bone marrow) in newly diagnosed people and in people who have not improved with treatment or who have improved after treatment with other medications but the condition returned. Daratumumab is in a class of medications called monoclonal antibodies. It works by helping the body to slow or stop the growth of cancer cells.